Latest in precision cancer medicine

Specific mutations in leukaemia patients' blood predicts survival

Causes and consequences of microRNA dysregulation in cancer

Sequencing multiple myeloma reveals a complex landscape of genetic lesions

Results from SCHOLAR-1 trial for DLBCL patients

Super-enhancer analysis reveals subtypes in AML and MDS

PD-1 enhances elotuzumab efficacy

Novel therapies for older patients with AML and MDS

Better screening programmes needed for haematological malignancies such as leukaemia

Chemo-genomic interrogation reveals JAK sensitive subgroup in AML

The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome

Advances in first line treatment options for MCL patients